Torrent Pharmaceuticals Ltd Q1 FY2023-24 consolidated PAT rises to Rs. 378 crores

Torrent Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 2625 crores during the period ended June 30, 2023 as compared to Rs. 2500 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 378 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 287 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 11.18 for the period ended June 30, 2023 as compared to Rs. 8.48 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 2625 crs	₹2500 crs	5.00%
Net Profit	₹378 crs	₹287 crs	31.71%
EPS	₹11.18	₹8.48	31.84%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 2625 crores during the period ended June 30, 2023 as compared to Rs.2377 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.378 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.354 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.11.18 for the period ended June 30, 2023 as compared to Rs.10.45 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 2625 crs	₹2377 crs	10.43%
Net Profit	₹378 crs	₹354 crs	6.78%
EPS	₹11.18	₹10.45	6.99%

Shares of Torrent Pharmaceuticals Limited was last trading in BSE at Rs. 2051.50 as compared to the previous close of Rs. 2061.55. The total number of shares traded during the day was 5294 in over 1201 trades.

The stock hit an intraday high of Rs. 2079.55 and intraday low of 2045.00. The net turnover during the day was Rs. 10917890.00.

Source : Equity Bulls

Keywords

TorrentPharmaceuticals Q1FY24 ResultUpdate